Bacterial vaccines are biological preparations that provide active acquired immunity to particular bacterial infections. They contain either killed or weakened forms of bacteria or purified components derived from bacteria like polysaccharides, toxins, or surface proteins. The most common types of bacterial vaccines available in the market are vaccines for tetanus, diphtheria, pertussis, Haemophilus influenza type B, pneumococcal disease, and meningococcal disease. They are used to prevent infectious diseases and reduce the risk of potential epidemics. With increasing government initiatives for immunization programs globally, the demand for bacterial vaccines is expected to rise substantially in the coming years.
The global Bacterial Vaccines Market is estimated to be valued at US$ 27.39 Mn in 2023 and is expected to exhibit a CAGR of 6.9% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics
Increasing government immunization programs worldwide is one of the major drivers propelling the bacterial vaccines market growth. Various government bodies across the globe are introducing national immunization programs and organizing extensive immunization drives to limit the occurrence of infectious diseases. For instance, in October 2021, the Indian government commenced the national ‘Har Ghar Dastak’ campaign to achieve 100% vaccination target against COVID-19. This large-scale campaign aimed to vaccinate all eligible beneficiaries, especially in remote areas. Such initiatives are raising awareness about immunization and increasing the adoption of various bacterial vaccines.
Another factor fueling the demand is the rising funding for bacterial vaccine development. Key organizations including the WHO, UNICEF, GAVI, and CEPI are offering financial support and grants to develop novel vaccines against drug-resistant bacterial strains. For example, in October 2020, CEPI announced investment of up to US$ 328 million to accelerate the development of vaccines against pathogens with epidemic potential including bacterial diseases like typhoid. The increasing R&D activities in this area are anticipated to broaden the product pipeline, thereby boosting market revenues over the forecast period.
Segment Analysis
The Bacterial Vaccines Market Demand is segmented into pneumococcal, DTP, meningococcal, and tuberculosis vaccines. Among these, pneumococcal vaccines dominate the market and accounted for over 40% share in 2021. Their dominance is attributed to growing initiatives by governments and international organizations to reduce morbidities and mortalities caused due to pneumococcal diseases. Pneumonia causes majority of deaths among children below 5 years, hence pneumococcal vaccines are administered widely to pediatric population.
PEST Analysis
Political: Governments of various countries have implemented national immunization programs to promote the uptake of bacterial vaccines. This has positively impacted the market growth. However, lack of awareness in low-income nations continues to hamper the effective implementation of vaccination drives.
Economic: The market has witnessed steady growth over the past few years owing to rising healthcare budgets of developed nations. Additionally, funding from international organizations has enabled improved access to bacterial vaccines in developing regions.
Social: Growing parental focus on immunizing children against bacterial infections is a key driver. However, misinformation regarding safety of certain vaccines continues to challenge their widespread adoption.
Technological: Advancements include vaccines targeting more pathogenic strains and combination vaccines offering protection against multiple strains. Such developments are extending the protective efficacy of vaccines.
Key Takeaways
The global bacterial vaccines market is expected to witness high growth over the forecast period. The global Bacterial Vaccines Market is estimated to be valued at US$ 27.39 Mn in 2023 and is expected to exhibit a CAGR of 6.9% over the forecast period 2024 to 2031.
Regional analysis
North America accounted for over 35% of the global market share in 2021 led by availability of advanced vaccines in the US. Mandatory vaccination requirements for school admission enhances the demand. In Europe, presence of universal healthcare and thriving vaccine production has aided market growth historically.
Key players
Key players operating in the bacterial vaccines market are Mondi Group, Kuraray Co. Ltd., Cortec Corporation, Arrow GreenTech Ltd., AMC (UK) Ltd., Aicello Corporation, Sekisui Chemical Co. Ltd., Neptun Technologies GmbH, and Mitsubishi Chemical Corporation. Mondi Group is one of the largest flexible packaging company globally. Kuraray Co. Ltd. is a Japanese manufacturer of chemicals and resins.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
